Randomised Crossover Trial of DBS of Differential PSA Regions in Parkinson's Disease and Tremor
NCT ID: NCT01945567
Last Updated: 2021-05-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
39 participants
INTERVENTIONAL
2012-08-31
2020-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Subthalamic Deep Brain Stimulation (DBS) in Parkinson's Disease
NCT02012647
PSA Versus STN DBS for TD-PD
NCT05382858
Low Frequency Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease
NCT03204526
Deep Brain Stimulation for Patients With Parkinson's Disease.
NCT03128567
Asymmetric Subthalamic Deep Brain Stimulation for Axial Motor Dysfunction in Parkinson's Disease
NCT03462082
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dorsal zona incerta
Up to 3 mA, 60 us, 130 Hz deep brain stimulation
Up to 3 mA, 60 us, 130 Hz deep brain stimulation
Caudal zona incerta
Up to 3 mA, 60 us, 130 Hz deep brain stimulation
Up to 3 mA, 60 us, 130 Hz deep brain stimulation
Empirical deep brain stimulation
Empirical unblinded deep brain stimulation programming using any posterior subthalamic area electrode contact(s) and stimulation parameters to optimise clinical outcome.
Empirical unblinded deep brain stimulation programming
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Up to 3 mA, 60 us, 130 Hz deep brain stimulation
Empirical unblinded deep brain stimulation programming
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Dementia with mini mental state examination score of less than 25/30
* Limited life expectancy due to a co-morbid condition
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Western Australia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Professor Christopher Lind
Professor, School of Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christopher Lind, MBChB, FRACS
Role: PRINCIPAL_INVESTIGATOR
The University of Western Australia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sir Charles Gairdner Hospital
Perth, Western Australia, Australia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012-039
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.